Zhongchen Ma

Shihezi, 832003, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

A Meta-Analysis of the Protective Efficacy of Brucella abortus S2308 Gene-Deletion Mutant Vaccines Compared to Conventional Vaccines in Mice.

A Meta-Analysis of the Protective Efficacy of Brucella abortus S2308 Gene-Deletion Mutant Vaccines Compared to Conventional Vaccines in Mice.

Journal: Microorganisms

Published: May 18, 2026

Brucella proline racemase protein A targets Tpl2 to promote IL-10 secretion for establishment of chronic infection.

Brucella proline racemase protein A targets Tpl2 to promote IL-10 secretion for establishment of chronic infection.

Journal: Frontiers in immunology

Published: February 10, 2026

A Novel Bicistronic Adenovirus Vaccine Elicits Superior and Comprehensive Protection Against BVDV.

A Novel Bicistronic Adenovirus Vaccine Elicits Superior and Comprehensive Protection Against BVDV.

Journal: Microorganisms

Published: December 29, 2025

The subunit vaccine of Lumpy skin disease virus elicits significant humoral and cell-mediated immune responses in mice.

The subunit vaccine of Lumpy skin disease virus elicits significant humoral and cell-mediated immune responses in mice.

Journal: Frontiers in veterinary science

Published: October 24, 2025

Mycoplasma bovis Infection Induces Apoptosis Through Gadd45/XIAP in Bovine Macrophages.

Mycoplasma bovis Infection Induces Apoptosis Through Gadd45/XIAP in Bovine Macrophages.

Journal: Microorganisms

Published: July 17, 2025

Brucella-infected macrophage-derived microparticles enhance the host anti-Brucella acquired immune response.

Brucella-infected macrophage-derived microparticles enhance the host anti-Brucella acquired immune response.

Journal: Veterinary microbiology

Published: June 14, 2025

Brucella-infected macrophage-derived Exosomes enhance the anti-Brucella acquired immune response.

Brucella-infected macrophage-derived Exosomes enhance the anti-Brucella acquired immune response.

Journal: International immunopharmacology

Published: June 13, 2025

A BtpB-Deleted Brucella Vaccine Strain Provides Dual Advantages: Enhanced Protection and Diagnostic Differentiation Capability in Mice.

A BtpB-Deleted Brucella Vaccine Strain Provides Dual Advantages: Enhanced Protection and Diagnostic Differentiation Capability in Mice.

Journal: Microbial biotechnology

Published: June 10, 2025

PRRSV GP4 subunit vaccine combined with adenovirus heterologous prime-boost immunization strategy induced a significant immune response in mice.

PRRSV GP4 subunit vaccine combined with adenovirus heterologous prime-boost immunization strategy induced a significant immune response in mice.

Journal: BMC veterinary research

Published: March 11, 2025

Brucella inactivated vaccine elicits immunity against B. melitensis infection in mice and guinea pigs.

Brucella inactivated vaccine elicits immunity against B. melitensis infection in mice and guinea pigs.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: February 10, 2025

A novel IgG-Fc-Fused multiepitope vaccine against Brucella: robust immunogenicity.

A novel IgG-Fc-Fused multiepitope vaccine against Brucella: robust immunogenicity.

Journal: Microbial cell factories

Published: January 22, 2025

Genome and Pathogenicity Analysis of an NADC30-like PRRSV Strain in China's Xinjiang Province.

Genome and Pathogenicity Analysis of an NADC30-like PRRSV Strain in China's Xinjiang Province.

Journal: Viruses

Published: January 08, 2025

Showing 1-12 of 30

Last Updated: 09/26/2026